Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Li‐Juan Zong"'
Autor:
Yu Ma, Chuan He, Youhui Gong, Lifang Qian, Qian Lu, Jinhua Li, Li‐Juan Zong, Jie Song, Zhifei Yin, Ying Shen
Publikováno v:
Health Science Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
Abstract Background and aims Electrical stimulation (ES) has been shown to substantially enhance the quality of life by alleviating pain in patients with chronic wounds. This study aimed to observe the effects of low‐frequency pulsed wearable ES at
Externí odkaz:
https://doaj.org/article/0285a353e3a74f149a6d975d2592dea5
Autor:
Xiao-Tao Zhang1,2, Li-Juan Zong3, Ru-Meng Jia3, Xin-Miao Qin3, Shi-Rong Ruan3, Lin-Lin Lu2,4, Ping Wang5, Liang Hu3, Wen-Tao Liu3, Yang Yang5, Yan Li1 liyan16766@163.com
Publikováno v:
Journal of Cancer Research & Therapeutics. Aug2023, Vol. 19 Issue 4, p1031-1039. 9p.
Autor:
Wen-Tao Liu, Xuefeng Wu, Chun-Yi Jiang, Yu Wang, Yang Yang, Yan Li, Xiaotao Zhang, Ya-Qian Zhao, Li-Juan Zong, Chao-Yu Wang, Kun Li, Fan Hu, Liang Hu, Tongtong Lin
Oxaliplatin is an antineoplastic agent frequently used in the treatment of gastrointestinal tumors. However, it causes dose-limiting sensorimotor neuropathy, referred to as oxaliplatin-induced peripheral neuropathy (OIPN), for which there is no effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7802e27832d931afdefe9b17acad0dd8
https://doi.org/10.1158/2326-6066.c.6551006
https://doi.org/10.1158/2326-6066.c.6551006
Autor:
Wen-Tao Liu, Xuefeng Wu, Chun-Yi Jiang, Yu Wang, Yang Yang, Yan Li, Xiaotao Zhang, Ya-Qian Zhao, Li-Juan Zong, Chao-Yu Wang, Kun Li, Fan Hu, Liang Hu, Tongtong Lin
Supplementary Data from NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171e6b6bc0db8376a10f38013cf7e3a1
https://doi.org/10.1158/2326-6066.22545698
https://doi.org/10.1158/2326-6066.22545698
Autor:
Wen-Tao Liu, Xuefeng Wu, Chun-Yi Jiang, Yu Wang, Yang Yang, Yan Li, Xiaotao Zhang, Ya-Qian Zhao, Li-Juan Zong, Chao-Yu Wang, Kun Li, Fan Hu, Liang Hu, Tongtong Lin
Supplementary Figure from NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0f1c561582262ab91ab34a17c49f0c
https://doi.org/10.1158/2326-6066.22545695.v1
https://doi.org/10.1158/2326-6066.22545695.v1
Autor:
Wen-Tao Liu, Xuefeng Wu, Chun-Yi Jiang, Yu Wang, Yang Yang, Yan Li, Xiaotao Zhang, Ya-Qian Zhao, Li-Juan Zong, Chao-Yu Wang, Kun Li, Fan Hu, Liang Hu, Tongtong Lin
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c061b15ecc679773fee80a4d19b53d0
https://doi.org/10.1158/2326-6066.22545689.v1
https://doi.org/10.1158/2326-6066.22545689.v1
Autor:
Xi-Ya Li, Ji-Chuan Wu, Ping Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen, Cheng-Long Hu, Ming-Yue Fei, Peng-Cheng Yu, Yi-Lun Jiang, Chun-Hui Xu, Bin-He Chang, Xin-Chi Chen, Li-Juan Zong, Jia-Ying Zhang, Ying Fang, Xiao-Jian Sun, Kai Xue, Li Wang, Shu-Bei Chen, Shi-Yu Jiang, Ai-ling Gui, Ling Yang, Juan J. Gu, Bao-Hua Yu, Qun-ling Zhang, Lan Wang
Publikováno v:
Leukemia.
The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy for these patients is urgently needed. Although ubiquitin-specific protease 1 (USP1) plays a key role
Autor:
Tongtong Lin, Liang Hu, Fan Hu, Kun Li, Chao-Yu Wang, Li-Juan Zong, Ya-Qian Zhao, Xiaotao Zhang, Yan Li, Yang Yang, Yu Wang, Chun-Yi Jiang, Xuefeng Wu, Wen-Tao Liu
Publikováno v:
Cancer immunology research. 10(12)
Oxaliplatin is an antineoplastic agent frequently used in the treatment of gastrointestinal tumors. However, it causes dose-limiting sensorimotor neuropathy, referred to as oxaliplatin-induced peripheral neuropathy (OIPN), for which there is no effec
Autor:
Cheng-Long Hu, Bing-Yi Chen, Zijuan Li, Tianbiao Yang, Chun-Hui Xu, Ruirui Yang, Peng-Cheng Yu, Jingyao Zhao, Ting Liu, Na Liu, Bin Shan, Qunling Zhang, Junhong Song, Ming-Yue Fei, Li-Juan Zong, Jia-Ying Zhang, Ji-Chuan Wu, Shu-Bei Chen, Yong Wang, Binhe Chang, Dan Hou, Ping Liu, Yilun Jiang, Xiya Li, Xinchi Chen, Chu-Han Deng, Yi-Yi Ren, Roujia Wang, Jiacheng Jin, Kai Xue, Ying Zhang, Meirong Du, Jun Shi, Ling-Yun Wu, Chun-Kang Chang, Shuhong Shen, Zhu Chen, Sai-Juan Chen, Xiaolong Liu, Xiao-Jian Sun, Mingyue Zheng, Lan Wang
Publikováno v:
Cell research. 32(12)
Aberrant self-renewal of leukemia initiation cells (LICs) drives aggressive acute myeloid leukemia (AML). Here, we report that UHRF1, an epigenetic regulator that recruits DNMT1 to methylate DNA, is highly expressed in AML and predicts poor prognosis
Autor:
Ji Chuan Wu, Peng Cheng Yu, Zhu Chen, Li Juan Zong, Chun Hui Xu, Na Liu, Ping Liu, Shu Bei Chen, Stephen D. Nimer, Jia Ying Zhang, Ming Sun, Yuan Liang Zhang, Cheng Long Hu, Bing Yi Chen, Ruo Fei Dai, Dan Hou, Sai Juan Chen, Qiu Hua Huang, Junhong Song, Fei Lan, Su Jiang Zhang, Qun-Ling Zhang, Xiao-Jian Sun, Lan Wang
Publikováno v:
Blood
SETD2, the histone H3 lysine 36 methyltransferase, previously identified by us, plays an important role in the pathogenesis of hematologic malignancies, but its role in myelodysplastic syndromes (MDSs) has been unclear. In this study, low expression